Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Being able to rapidly reprogram Angry Kitten pods remotely based on the real-time threat environment would be hugely valuable ...
It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.
Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...
A single-atom nanozyme mimicking cytochrome c oxidase restores mitochondrial energy production in stem cells, shifting their ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced positive data from its HT-VA study, conducted under its Cooperative Research and Development ...
Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected ...
Researchers highlighted how an arginine- and proline-restricted diet combined with eflornithine reprogrammed MYCN-driven ...
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the Clinical-Grade, ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results